Benzinga's Top Upgrades

Analysts at Piper Jaffray upgraded Fusion-io

from “neutral” to “overweight.” The target price for Fusion-io has been raised from $12 to $17. Fusion-io's shares closed at $13.60 yesterday. Analysts at JP Morgan upgraded Marvell Technology Group

from “neutral” to “overweight.” The target price for Marvell Technology Group has been raised from $14 to $16. Marvell Technology's shares closed at $12.57 yesterday. Analysts at Morgan Stanley upgraded Biomed Realty Trust

from “equal-weight” to “overweight.” The target price for Biomed Realty Trust is set to $23. Biomed Realty Trust's shares closed at $18.61 yesterday. Analysts at Citigroup upgraded M.D.C. Holdings

from “sell” to “neutral.” The target price for M.D.C. Holdings has been raised from $23 to $29. M.D.C. Holdings' shares closed at $29.37 yesterday.